References
- Lopez-Navarro ER, Park S, Willey JZ, Gutierrez J. Dolichoectasia: a brain arterial disease with an elusive treatment. Neurol Sci 2022; 43: 4901-8. https://doi.org/10.1007/s10072-022-06078-9
- Del Brutto VJ, Ortiz JG, Biller J. Intracranial arterial dolichoectasia. Front Neurol 2017; 8: 344.
- Yu Y, Moseley IF, Pullicino P, McDonald WI. The clinical picture of ectasia of the intracerebral arteries. J Neurol Neurosurg Psychiatry 1982; 45: 29-36. https://doi.org/10.1136/jnnp.45.1.29
- Del Brutto VJ, Gutierrez J, Goryawala MZ, Sacco RL, Rundek T, Romano JG. Prevalence and clinical correlates of intracranial dolichoectasia in individuals with ischemic stroke. Stroke 2021; 52: 2311-8. https://doi.org/10.1161/STROKEAHA.120.032225
- Pico F, Labreuche J, Amarenco P. Pathophysiology, presentation, prognosis, and management of intracranial arterial dolichoectasia. Lancet Neurol 2015; 14: 833-45. https://doi.org/10.1016/S1474-4422(15)00089-7
- Smoker WR, Corbett JJ, Gentry LR, Keyes WD, Price MJ, McKusker S. High-resolution computed tomography of the basilar artery: 2. Vertebrobasilar dolichoectasia: clinical-pathologic correlation and review. AJNR Am J Neuroradiol 1986; 7: 61-72.
- Do TM, Unis GD, Kattar N, Ananth A, McCoul ED. Neuromodulators for atypical facial pain and neuralgias: a systematic review and meta-analysis. Laryngoscope 2021; 131: 1235-53. https://doi.org/10.1002/lary.29162
- Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: an overview from pathophysiology to pharmacological treatments. Mol Pain 2020; 16: 1744806920901890.
- Park J, Park HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel) 2017; 9: 260.
- Tambasco N, Filidei M, Nigro P, Parnetti L, Simoni S. Botulinum toxin for the treatment of hemifacial spasm: an update on clinical studies. Toxins (Basel) 2021; 13: 881.